Rxsight, INC Form 4 insider transactions

Eric Weinberg, Co-President and Chief Commercial Officer of RxSight, Inc., was granted stock options to purchase 125,000 shares of common stock on February 27, 2025.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., was granted 125,000 stock options on February 27, 2025, according to a Form 4 filing with the SEC.

Shelley Thunen, CFO of RxSight, Inc., reports the acquisition of 125,000 stock options on February 27, 2025.

RxSight's President and CEO, Ronald M. Kurtz, acquired 215,000 stock options on February 27, 2025, according to a Form 4 filing with the SEC.

A director of RxSight, Inc. sold 3,519 shares of common stock at an average price of $30.8662 per share under a pre-arranged 10b5-1 trading plan.

Director Jesse Anderson Corley indirectly acquired additional shares of RxSight stock through spousal and trust purchases, while also holding a significant number of shares directly and indirectly through other entities.

RxSight's Co-President and COO, Ilya Goldshleger, exercised stock options and sold shares on November 29, 2024, according to a recent SEC filing.

RxSight director Shweta Maniar sold 3,782 shares of common stock at $45.88 per share on November 26, 2024, under a pre-arranged 10b5-1 trading plan.

An RxSight executive, Ilya Goldshleger, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

An RxSight executive, Ilya Goldshleger, executed stock option exercises and subsequent sales under a pre-arranged 10b5-1 trading plan.

RxSight's Co-President and COO, Ilya Goldshleger, exercised stock options and sold shares under a pre-arranged trading plan.

Director Jesse Anderson Corley of RxSight, Inc. has reported purchasing shares of the company's common stock in multiple transactions.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock on November 4, 2024, according to a Form 4 filing with the SEC.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock between October 16 and October 18, 2024, according to a recent SEC filing.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock on October 4 and October 8, 2024, according to a Form 4 filing with the SEC.

Shelley Thunen, CFO of RxSight, exercised stock options and sold shares of the company's common stock on October 1, 2024, according to a Form 4 filing with the SEC.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock on September 26 and 30, 2024, according to a Form 4 filing with the SEC.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., executed stock options and sold shares of common stock between September 20 and September 23, 2024, according to a Form 4 filing with the SEC.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold 3,100 shares of common stock on September 17, 2024, according to a recent SEC filing.

Ronald Kurtz, President and CEO of RxSight, Inc., exercised stock options and disposed of shares on August 9, 2024, according to a Form 4 filing with the SEC.

Eric Weinberg, Co-President and Chief Commercial Officer of RxSight, Inc., was granted stock options to purchase 50,000 shares of common stock on August 7, 2024.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., acquired 50,000 stock options on August 7, 2024, according to a Form 4 filing with the SEC.

Shelley Thunen, CFO of RxSight, Inc., reports the acquisition of 50,000 stock options on August 7, 2024.

Ilya Goldshleger, Co-President and COO of RxSight, Inc., executed multiple sales of common stock on August 5, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Shelley Thunen, CFO of RxSight, Inc., exercised stock options and acquired 16,505 shares of common stock at a price of $4.34 on July 15, 2024.